0001213900-21-036321.txt : 20210709 0001213900-21-036321.hdr.sgml : 20210709 20210709150525 ACCESSION NUMBER: 0001213900-21-036321 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210709 DATE AS OF CHANGE: 20210709 EFFECTIVENESS DATE: 20210709 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Boston Therapeutics, Inc. CENTRAL INDEX KEY: 0001473579 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 270801073 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-405753 FILM NUMBER: 211082672 BUSINESS ADDRESS: STREET 1: 354 MERRIMACK STREET STREET 2: #4 CITY: LAWRENCE STATE: MA ZIP: 01843 BUSINESS PHONE: (603) 935-9799 MAIL ADDRESS: STREET 1: 354 MERRIMACK STREET STREET 2: #4 CITY: LAWRENCE STATE: MA ZIP: 01843 FORMER COMPANY: FORMER CONFORMED NAME: AVANYX Therapeutics, Inc. DATE OF NAME CHANGE: 20091001 D 1 primary_doc.xml X0708 D LIVE 0001473579 Boston Therapeutics, Inc. 354 MERRIMACK STREET #4 LAWRENCE MA MASSACHUSETTS 01843 603-935-9799 DELAWARE None AVANYX Therapeutics, Inc. Corporation true David Ludvigson 354 MERRIMACK STREET #4 Lawrence MA MASSACHUSETTS 01843 Executive Officer Director Conroy Chi-Heng Cheng 354 MERRIMACK STREET #4 Lawrence MA MASSACHUSETTS 01843 Director Biotechnology Decline to Disclose 06b false 2021-06-25 false true true true Convertible Note and Warrrants false 0 8434778 8434778 0 false 5 0 0 0 false Boston Therapeutics, Inc. /s/ David Ludvigson David Ludvigson Chief Executive Officer 2021-07-09